Epsilon Healthcare Limited (HDRPF)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Breakdown | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -2.57 Million | -5.42 Million | -8.69 Million | -7.85 Million | -5.85 Million | -1.87 Million |
| Net Income | -13.28 Million | -9.24 Million | -10.53 Million | -11.7 Million | -8.61 Million | -2.55 Million |
| Depreciation & Amortization | 1.85 Million | 1.14 Million | 1.56 Million | 222.09 Thousand | 115.13 Thousand | 23.62 Thousand |
| Deferred income taxes | - | -701.21 Thousand | -7311.00 | -1.15 Million | - | - |
| Stock-based compensation | - | 1.09 Million | 7311.00 | 1.15 Million | 1.94 Million | 359.67 Thousand |
| Change in working capital | 3.2 Million | -988.38 Thousand | -119.88 Thousand | -147.15 Thousand | -566.57 Thousand | 247.3 Thousand |
| Other non-cash items | 5.65 Million | 7.63 Million | 395.21 Thousand | 3.77 Million | 3.85 Million | -389.15 Thousand |
| Investing Cash Flow | -529.4 Thousand | -737.59 Thousand | -1.73 Million | -714.67 Thousand | -3.05 Million | -759.11 Thousand |
| Investments in PPE | -529.4 Thousand | -747.71 Thousand | -1.23 Million | -714.67 Thousand | -3.03 Million | -657.91 Thousand |
| Acquisitions | - | -39.88 Thousand | -496.54 Thousand | - | -27.16 Thousand | 195.76 Thousand |
| Investment purchases | - | - | - | - | - | -296.96 Thousand |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | 50 Thousand | - | - | - | -300 Thousand |
| Financing Cash Flow | 1.6 Million | 1.47 Million | 14.59 Million | 5.78 Million | 4.2 Million | 12.8 Million |
| Debt repayment | -1.28 Million | -477.15 Thousand | -3.76 Million | -1.26 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | 2.88 Million | - | - | - | - | - |
| Common Stock Issuance | 2.88 Million | 2.51 Million | 10.83 Million | 4.52 Million | 4.2 Million | 14.48 Million |
| Other Financing Activities | -2.88 Million | -564.7 Thousand | 7.52 Million | 2.52 Million | 4.2 Million | -1.67 Million |
| Accounts receivables | -795.15 Thousand | -843.74 Thousand | -1.07 Million | -668.89 Thousand | -169.49 Thousand | -8733.00 |
| Accounts payables | 1.58 Million | 311.97 Thousand | 1.34 Million | 528 Thousand | -243.97 Thousand | 854.81 Thousand |
| Inventory | 2.42 Million | -456.6 Thousand | -386.13 Thousand | -6255.00 | -153.1 Thousand | -598.77 Thousand |
| Other working capital | - | - | - | - | -153.1 Thousand | -598.77 Thousand |
| Cash at beginning of period | 2.33 Million | 6.96 Million | 3.55 Million | 6.33 Million | 11.03 Million | 885.37 Thousand |
| Cash at end of period | 861.98 Thousand | 2.33 Million | 6.96 Million | 3.55 Million | 6.33 Million | 11.03 Million |
| Capital Expenditure | -529.4 Thousand | -747.71 Thousand | -1.23 Million | -714.67 Thousand | -3.03 Million | -657.91 Thousand |
| Effect of forex changes on cash | 19.34 Thousand | 19.34 Thousand | -5640.00 | 6767.00 | 209.00 | -19.53 Thousand |
| Net cash flow / Change in cash | -1.47 Million | -4.63 Million | 3.41 Million | -2.78 Million | -4.7 Million | 10.15 Million |
| Free Cash Flow | -3.1 Million | -6.17 Million | -9.92 Million | -8.57 Million | -8.88 Million | -2.53 Million |
| Breakdown | 2023 Q2 | 2023 Q1 | 2022 FY | 2022 Q4 | 2022 Q3 | 2022 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -358.56 | -358.55 Thousand | -13.28 Million | -2.6 Million | -2.6 Million | -8.07 Million |
| Depreciation & Amortization | 543.06 | 543.06 Thousand | 1.85 Million | 597.47 Thousand | 597.47 Thousand | 660.56 Thousand |
| Deferred income taxes | - | - | - | -3.16 Million | - | - |
| Stock-based compensation | - | - | - | -41.32 Thousand | -41.32 Thousand | 41.32 Thousand |
| Change in working capital | - | - | 3.2 Million | 812.59 Thousand | 812.59 Thousand | - |
| Other non-cash items | -432.32 | -432.31 Thousand | 5.65 Million | 336.35 Thousand | 336.35 Thousand | 7.96 Million |
| Investing Cash Flow | - | - | -529.4 Thousand | -185.45 Thousand | -185.45 Thousand | -158.49 Thousand |
| Investments in PPE | - | - | -529.4 Thousand | -185.45 Thousand | -185.45 Thousand | -158.49 Thousand |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | - |
| Financing Cash Flow | -32.45 | -32.45 Thousand | 1.6 Million | 1.02 Million | 1.02 Million | -436.43 Thousand |
| Debt repayment | -64.9 Thousand | - | -1.28 Million | -245.48 Thousand | - | -1.03 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | 2.88 Million | - | - | - |
| Common Stock Issuance | - | - | 2.88 Million | 2.28 Million | - | 600 Thousand |
| Other Financing Activities | -32.45 | -32.45 Thousand | -2.88 Million | 1.02 Million | 1.02 Million | -218.21 Thousand |
| Accounts receivables | - | - | -795.15 Thousand | -397.57 Thousand | -397.57 Thousand | - |
| Accounts payables | - | - | 1.58 Million | - | - | - |
| Inventory | - | - | 2.42 Million | 1.21 Million | 1.21 Million | - |
| Other working capital | - | - | - | - | - | - |
| Cash at beginning of period | 861.98 Thousand | - | 2.33 Million | 965.35 Thousand | 965.35 Thousand | 2.33 Million |
| Cash at end of period | 301.46 Thousand | -280.26 Thousand | 861.98 Thousand | 861.98 Thousand | 913.66 Thousand | 965.35 Thousand |
| Capital Expenditure | - | - | -529.4 Thousand | -185.45 Thousand | -185.45 Thousand | -158.49 Thousand |
| Effect of forex changes on cash | - | - | 19.34 Thousand | 11.83 Thousand | 11.83 Thousand | -2159.00 |
| Net cash flow / Change in cash | -560.52 Thousand | -280.26 Thousand | -1.47 Million | -103.36 Thousand | -51.68 Thousand | -1.37 Million |
| Free Cash Flow | -247.81 | -247.81 Thousand | -3.1 Million | -1.08 Million | -1.08 Million | -929.46 Thousand |
0HIN
ELM
002475
MAHLIFE
KYP
300181